Table 3.
PBMC* | 3H-TdR incorporation (103 ct/min ± s.d.) | Percent of CD56+ cells in cultured PBMC |
---|---|---|
HMB patient | 72·2 ± 3·1 | 98 |
Healthy control 1 | 13·8 ± 0·8 | 42 |
Healthy control 2 | 14·3 ± 1·1 | 35 |
PBMC from a hypersensitivity to mosquito bites (HMB) patient or healthy individuals were cultured in complete medium supplemented with 50 U/ml rIL-2 for 5 days, and subjected to proliferation assay and flow cytometric analysis with PE-conjugated anti-CD56 MoAb.